A proposal to create a rare disease center of excellence at the US FDA would allow closer collaboration between experts in the product centers, as well as add more dedicated leadership within the agency and access more expertise outside it.
Attorneys Frank Sasinowski and James Valentine, of Hyman, Phelps and McNamara, collaborated on a paper describing the potential structure...







